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Abstract
Background and Aims: High protein (HP) diets are suggested to positively modulate obesity and associated increased
prevalence of non-alcoholic fatty liver (NAFLD) disease in humans and rodents. The aim of our study was to detect
mechanisms by which a HP diet affects hepatic lipid accumulation.
Methods: To investigate the acute and long term effect of high protein ingestion on hepatic lipid accumulation under both
low and high fat (HF) conditions, mice were fed combinations of high (35 energy%) or low (10 energy%) fat and high (50
energy%) or normal (15 energy%) protein diets for 1 or 12 weeks. Effects on body composition, liver fat, VLDL production
rate and the hepatic transcriptome were investigated.
Results: Mice fed the HP diets displayed a lower body weight, developed less adiposity and decreased hepatic lipid
accumulation, which could be attributed to a combination of several processes. Next to an increased hepatic VLDL
production rate, increased energy utilisation due to enhanced protein catabolic processes, such as transamination, TCA
cycle and oxidative phosphorylation was found upon high protein ingestion.
Conclusion: Feeding a HP diet prevented the development of NAFLD by enhancing lipid secretion into VLDL particles and a
less efficient use of ingested calories.
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Introduction
Within the context of the metabolic syndrome clear links are
demonstrated between non-alcoholic fatty liver disease (NAFLD)
and insulin resistance, type 2 diabetes mellitus and obesity [1,2].
NAFLD develops from hepatocellular steatosis via non-alcoholic
steatohepatitis (NASH) to fibrosis and can eventually end up in
irreversible cirrhosis [2,3]. In western populations the prevalence
of NAFLD is estimated to be between 30–46% [4]. In obese
patients the prevalence of developing NASH or fibrosis was found
to be even increased to 60–70% [5,6]. In addition to genetic
predisposition, amongst others in apolipoprotein encoding genes
[7,8], environment and lifestyle may affect the development of
fatty liver. Patients suffering from NAFLD were observed to
consume more food from fast food restaurants and have a more
sedentary lifestyle as well as a lower fitness level compared to
people not diagnosed with NAFLD [4,9]. In intervention studies
which targeted regression of hepatic lipids, an increase in physical
activity was mostly successful in combination with a reduction in
energy intake [10,11].
The amount of hepatic lipids can be modified by the
macronutrient composition of the diet by modulating hepatic
fatty acid uptake, lipogenesis, fatty acid oxidation and triglyceride
secretion [12,13]. It has been observed that high fat (HF) diets lead
to hepatic lipid accumulation in both humans [14,15] and rodents
[16,17]. Recently, evidence links a high intake of simple
carbohydrates and fructose, mainly by consumption of soft drinks,
with the development of NAFLD and even NASH [18,19]. In rats
fed a diet rich in fructose, an increase in hepatic fat was likewise
observed [20,21]. In contrast, diets high in protein are suggested to
prevent and decrease hepatic lipid content. In rodents, it has been
shown that augmenting the amount of protein during high fat
feeding results in reduced adiposity and liver fat [22,23]. In
human, the increase in intrahepatocellular lipid (IHCL) deposition
induced by a HF diet was reduced when dietary protein was
augmented [15]. Most of these studies, however, were short term
interventions and long term treatment might lead to different
results.
The present study in mice aims at analysing mechanisms
reducing hepatic lipid content in response to a HP diet. Mice were
fed different combinations of high fat and high protein diets for 1
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or 12 weeks to investigate the acute and long term effect of such a
diet on body adiposity, liver fat, VLDL production rate and
hepatic gene expression. We hypothesise that augmenting the
amount of dietary protein affects liver lipid uptake, de novo
lipogenesis, nutrient oxidation and VLDL secretion.
Materials and Methods
Ethics statement
All animal experiments were approved by the Animal Exper-
imentation Board at Wageningen University (record #2010017)
and carried out according to the guidelines of the European
Convention of Vertebrate Animals Used for Experimentation,
under European Council Directive 86/609/EEC dated Novem-
ber, 1986.
Animals and diets
Male C57BL/6J mice aged 8 weeks were purchased from
Charles River (L’Arbresle, France) and housed in pairs in the light
and temperature-controlled animal facility of Wageningen Uni-
versity (12:12 h reversed light/dark cycle, 2062uC). At 10 weeks
of age, mice were stratified according to their bodyweight into 9
diet groups (n = 10 per group). Diets were provided as powder in
specifically designed food cups to minimise spillage. All groups
received a low fat-normal protein diet (LF-NP, 10 and 15 energy%
from fat and protein, respectively) as run-in of two weeks prior to
the dietary intervention. One group was sacrificed after the run-in
period to serve as reference group. The other groups either
continued on the LF-NP diet or were switched to a high fat-
normal protein (HF-NP, 35 and 15 energy% from fat and protein,
respectively), a low fat-high protein (LF-HP, 10 and 50 energy%
from fat and protein, respectively) or a high fat-high protein (HF-
HP, 35 and 50 energy% from fat and protein, respectively) diet
which they received for 1 or 12 weeks. For diet compositions see
table 1. Body weight was recorded twice a week at the end of the
light phase. Food intake was measured daily by weighing back the
food cups when replaced with fresh food at the end of the light
phase. Spilled feed was collected and taken into account in the
analysis. The week prior to sacrifice, mice were habituated to a
modified feeding schedule. Food was removed at the beginning of
the light phase. One hour after beginning of the dark phase, mice
received a calibrated meal of 12.1 kJ to be consumed during
2 hours before getting ad libitum access to their habitual diet. The
day of sacrifice, mice received the calibrated meal at the habitual
time and were anaesthetised with Isoflurane 2 hours later. Blood
was taken by orbital puncture and plasma was stored. Liver and
epididymal adipose tissue were removed, weighed and snap frozen
in liquid nitrogen. Tissue was stored at 80uC until further analysis.
Liver phenotyping
Liver dry weight was determined by lyophilisation of samples at
240/250uC and 10 Torr. Water content was calculated
subsequently. Liver protein and triglycerides were determined in
5% liver homogenates prepared in buffer containing 2 mM EDTA
and 10 mM Tris at pH 7.5 using enzymatic colorimetric assays
(Protein Determination Kit, Cayman Chemical Company, Ann
Arbor, Michigan; Triglycerides liquicolor mono, Human Diag-
nostics, Wiesbaden, Germany). For oil red O/haematoxylin
staining frozen livers were sectioned at 5 mM in a Cryostat (Leica
Microsystems BV, Rijswijk, the Netherlands), mounted on glass
slides and air-dried for 30 minutes at room temperature. Sections
were fixed in 4% buffered formaldehyde for 10 minutes prior to
staining which was performed using standard protocols. Pictures of
liver sections were taken with a light microscope (Olympus BX41,
Essex, UK) at 20x magnification.
VLDL production
VLDL production was determined on an additional set of mice
(n = 9/group) after feeding the 4 diets for 1 week. Diets, treatment,
food intake and body weight development were highly similar to
the first set (data not shown). The experiment started at the
beginning of the dark phase. After 12 hours of fasting mice were
Table 1. Diet Compositions.1
Low fat-normal protein diet
(LF-NP)
High fat-normal protein
diet (HF-NP)
Low fat-high protein diet
(LF-HP)
High fat-high protein diet
(HF-HP)
Metabolisable energy, kJ/g 16.1 18.5 16.1 18.5
g/kg dry matter
Total milk protein2 140 160 484 580
Cornstarch3 361.35 291.3 189.35 80
Sucrose4 361.35 291.4 189.35 80
Soybean oil5 40 40 40 40
Palm oil5 0 120 0 123
AIN 93M mineral mix6 35 35 35 35
AIN 93V vitamin mix6 10 10 10 10
a-Cellulose7 50 50 50 50
Choline6 2.3 2.3 2.3 2.3
1All dietary components were purchased (sources given below) or prepared by UPAE (Unite´ de Pre´paration des Aliments Expe´rimentaux, French National Institute of
Agronomic Research, INRA, Jouy en Josas, France).
2Nutrinov, Rennes, France.
3Cerestar, Haubourdin, France.
4Eurosucre, Paris, France.
5Bailly SA, Aulnay-sous-bois, France.
6ICN biochemicals, Cleveland, OH.
7Medias filtrants Durieux, Torcy, France.
doi:10.1371/journal.pone.0047303.t001
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anaesthetised by an intra-peritoneal injection of hypnorm and
dormicum (5x diluted; 0.1 ml/10 g bodyweight). Subsequently the
LPL-inhibitor tyloxapol (Triton WR1339, Sigma, 0.5 mg/10 g
bodyweight as 15% solution (w/w) in saline) was injected intra-
orbitally. Plasma was sampled from tail bleedings and triglyceride
and glycerol concentrations were measured every 30 minutes for
180 minutes to determine VLDL production. VLDL-TG produc-
tion rate was determined from the slope of the curve from all
individual mice.
Plasma measurements
Plasma triglyceride concentration was determined using an
enzymatic colorimetric test (Triglycerides liquicolor mono,
Human Diagnostics, Wiesbaden, Germany). Concentrations were
corrected for free plasma glycerol (Free glycerol FS*, DiaSys
Diagnostic Systems GmbH, Holzheim, Germany). For determi-
nation of plasma b-hydroxybutyrate, the enzymatic assay b-
Hydroxybutyrate LiquiColor (Stanbio Laboratory, Boerne, Texas)
was used. Plasma leptin was measured using the Leptin (Mouse/
Rat) ELISA (ALPCO Diagnostics, Salem, New Hampshire).
Statistical analysis
All data are expressed as means 6 SD. Effects of increased
dietary protein and fat within one time point were tested for
statistical significance using general linear model with HP and HF
as fixed factors in PASW Statistics 18.0 software (SPSS Inc.,
Chicago, Illinois). Mean values were compared to the reference
group using one way ANOVA and Dunnett as post hoc test. Body
weight was tested using a linear mixed model with diet as main
and time as repeated factor. Least significant difference (LSD) test
was used as post hoc test. Effects of the diets on food intake and
VLDL production rate were tested using one way ANOVA. For
all tests, p-values #0.05 were considered to be statistically
significant.
Liver transcriptome analysis
Total RNA was extracted from liver tissue with TRIzol reagent
(Invitrogen, Breda, the Netherlands) and purified using SV total
RNA isolation system (Promega, Leiden, the Netherlands).
Concentrations of RNA samples were determined on a NanoDrop
ND-1000 UV-Vis spectrophotometer (Isogen, Maarssen, the
Netherlands). Total purified liver RNA of 5 mice per group was
subsequently pooled at a concentration of 500 ng/mouse. Quality
of the pooled RNA was assessed on an Agilent 2100 bioanalyzer
with the 6000 Nano Kit using the Eukaryote Total RNA Nano
assay (Agilent Technologies, Amsterdam, the Netherlands). RNA
was judged as being suitable for array hybridization only if samples
showed intact bands corresponding to the 18S and 28S ribosomal
RNA subunits, displayed no chromosomal peaks or RNA
degradation products and had a RNA integrity number (RIN)
above 8.0. The Ambion WT Expression kit (Life Technologies, P/
N 4411974) in conjunction with the Affymetrix GeneChip WT
Terminal Labelling kit (Affymetrix, Santa Clara, CA; P/N
900671) was used for the preparation of labelled cDNA from
100 ng of total RNA without rRNA reduction. Samples were
hybridized on Affymetrix GeneChip Mouse Gene 1.0 ST arrays.
Quality control and normalisation were performed using Biocon-
Figure 1. Body composition and food intake. Whereas cumulative food intake (A) did not differ (mean 6 SD), ad libitum fed C57BL/6J mice
(n = 10 per group) in the HF-NP group developed a higher body weight (B) compared to the other groups (mean 6 SEM). Epididymal adipose tissue
mass (C) and plasma leptin (D) are likewise increased in the HF-NP group. Effects of increased dietary protein (P) and fat (F) within one time point
were tested using general linear model with P and F as fixed factors. * represents values significantly different from the reference group (ref.) as
determined by one way ANOVA: *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0047303.g001
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Figure 2. Hepatic steatosis. In mice fed the LF-NP and HF-NP large amounts of lipid droplets can be detected after 1 week and 12 weeks of dietary
intervention. Mice fed the high protein diets (LF-HP and HF-HP) these lipid droplets are almost absent. (A) Oil red O staining of representative 5 mm
liver sections of the 8 groups. Pictures were taken with a light microscope at 20x magnification. Bar represents 50 mm. (B) Hepatic triglycerides (mean
expressed in mg/g liver) are decreased by HP feeding after 1 and 12 weeks and increased by HF feeding after 12 weeks. Effects of increased dietary
protein (P) and fat (F) within one time point were tested using general linear model with P and F as fixed factors. * represents values significantly
different from the reference group (ref.) as determined by one way ANOVA: *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0047303.g002
Table 2. Liver weight and composition (means 6 SD) of C57BL/6J mice fed four different diets for 1 and 12 weeks.
Liver Time point LF-NP HF-NP LF-HP HF-HP p-value (HP) p-value (HF)
Total weight
(g)
Reference 1.0860.07 - - - - -
1 week 1.0660.15 1.0760.15 1.3460.07*** 1.2260.14* #0.0001*** 0.2339
12 weeks 1.1160.10 1.1560.12 1.2460.10* 1.2160.12 0.0159* 0.7723
Dry weight
(g)
Reference 0.3060.12 - - - - -
1 week 0.3560.14 0.3960.06 0.4460.06* 0.4060.05 0.0866 0.9133
12 weeks 0.3560.10 0.4060.15 0.4060.10 0.4460.03* 0.3963 0.3958
Water content
(g)
Reference 0.7660.13 - - - - -
1 week 0.7060.16 0.6860.11 0.9060.08 0.8260.10 0.0001*** 0.1662
12 weeks 0.7660.16 0.7660.13 0.8360.08 0.7860.10 0.0442* 0.7989
Protein content
(g/g liver)
Reference 0.7960.12 - - - - -
1 week 0.7660.13 0.8760.12 0.7760.17 0.8360.10 0.7560 0.0444*
12 weeks 0.8460.12 0.8060.10 0.8160.12 0.8560.17 0.8208 0.9961
Groups are compared to the reference group. High protein (HP) and high fat (HF) feeding was tested within one time point.
*expresses significant difference to reference group: *p#0.05, **p#0.01, ***p#0.001.
doi:10.1371/journal.pone.0047303.t002
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ductor packages integrated in an on-line pipeline [24]. Probe sets
were redefined according to Dai et al. [25]. Probes were
reorganized based on the Entrez Gene database, build 37, version
2 (remapped CDF v14). Normalised expression estimates of probe
sets were computed by the robust multiarray (RMA) analysis
algorithm available in the Bioconductor library AffyPLM using
default settings [26]. Array data have been submitted to the Gene
Expression Omnibus and is available under accession number
GSE37897.
Gene set enrichment analysis (GSEA) and enrichment
maps
Changes in gene expression due to dietary protein independent
of intervention duration and background diet were related to
functional changes using gene set enrichment analysis (GSEA)
[27]. For each of the 21 212 genes on the array, the ratio of the
mean signal intensity of the HP groups and the mean signal
intensity of the NP groups was calculated and ranked. Subse-
quently signal intensity ratios were analysed for over- or
underrepresentation in predefined gene sets derived from Gene
Ontology, KEGG, National Cancer Institute, PFAM, Biocarta,
Reactome and WikiPathways pathway databases. Only gene sets
consisting of more than 15 and fewer than 500 genes were taken
into account. The statistical significance of GSEA results was
determined using 1 000 permutations. The Enrichment Map
plugin for Cytoscape was used for visualization and interpretation
of the GSEA results [28,29]. The enrichment map was generated
with gene sets that passed conservative significance thresholds (p-
value ,0.005, False Discovery Rate (FDR) ,0.1, Jaccard Overlap
Combined Cut-off .0.375). This resulted in a network of 154
nodes (gene sets), of which 125 were positively and 29 were
negatively enriched. Clusters of processes were manually circled
and assigned a summarising label. A high resolution version of the
enrichment map containing the names of all gene sets can be
found in supporting information (Figure S1). For selected clusters
of processes, genes contributing to the enrichment of the gene sets
were extracted. For each of those genes, fold changes (FC) of signal
intensity of the treatment group in comparison with the reference
group were calculated and expressed in a heat map (Table S1).
Additionally, genes contained in gene sets describing fatty acid
oxidation are expressed in table S1.
Results
HP feeding reduced high fat diet-induced body weight
gain
Cumulative food intake did not differ between the dietary
groups (p = 0.3235) (Figure 1 A). However, only mice fed the HF-
NP, but not those fed the HF-HP diet, gained significantly more
weight (p,0.0001) compared to the other groups during the entire
dietary intervention period (Figure 1 B). This was accompanied by
a high fat-induced larger epididymal adipose tissue mass after 12
weeks (p = 0.0003, Figure 1 C). After increasing dietary protein
content, adipose tissue mass of HP-fed mice was significantly lower
compared to NP-fed mice already after 1 week of diet (p = 0.0001).
This effect was even stronger after 12 weeks (p#0.0001). In line
with these findings plasma leptin concentrations were significantly
elevated by high fat feeding (p= 0.0108) over 12 weeks, while they
were significantly lower after high protein feeding (p#0.0001,
Figure 1 D).
HP feeding induced lower intrahepatic lipid
accumulation
Augmenting dietary protein leads to an increase in liver weight
compared to the reference group after both 1 and 12 weeks of diet
(Table 2). The higher liver weight might partly be explained by
increased water content in response to a HP diet after 1 week
(p = 0.0001) and 12 weeks (p = 0.0442). Effects on dry weight are
less pronounced although a significant increase after 1 week in the
LF-HP group and after 12 weeks was detected in the HF-HP
group compared to the reference group. Liver protein content was
increased by HF feeding only after 1 week (p = 0.0444). To
investigate the effect of high protein feeding on hepatic steatosis,
Figure 3. Fasted and postprandial plasma values. Fasted plasma
triglyceride concentration after Triton WR1339 injection (A). Hepatic
VLDL production rate is lower after 1 week of HF-NP feeding (mean 6
SEM). Plasma concentrations 2 hours postprandial to a standardised
meal indicating increased TG (B) and BHB (C) in HP-fed mice in
comparison with NP-fed mice. Effects of increased dietary protein (P)
and fat (F) within one time point were tested using general linear model
with P and F as fixed factors. * represents values significantly different
from the reference group (ref.) as determined by one way ANOVA:
*p#0.05, **p#0.01, ***p#0.001. # represents significant difference
from all other groups as determined using one way ANOVA.
doi:10.1371/journal.pone.0047303.g003
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frozen liver sections were stained for lipids with oil red O. Mice fed
the LF-NP and HF-NP diet show signs of hepatic steatosis
characterised by lipid droplets after 1 week of the dietary
intervention and maintained it for the following weeks (Figure 2
A). Animals fed the high protein diets (LF-HP and HF-HP) were
visibly protected from hepatic lipid accumulation as shown by the
absence of lipid droplets on the liver sections. Quantitaive
measurements demonstrated that hepatic triglyceride levels were
only significantly elevated in the HF-NP group after 12 weeks
intervention compared to the reference group (Figure 2 B). At the
same time HP feeding significantly lowered hepatic triglycerides
both after 1 and 12 weeks (p#0.0001) independent of the fat
content of the background diet.
HP feeding restored the HF-induced reduction in VLDL
production rate and increased postprandial plasma TG
and b-hydroxybutyrate
Hepatic VLDL production was determined in fasted mice after
1 week of dietary intervention (Figure 3 A). VLDL production rate
of HF-NP fed mice was decreased by 26% compared to LF-NP
animals (2.5960.09 vs. 3.4960.07 mM/h for HF-NP and LF-NP,
respectively, p = 0.0234). This effect was blunted when fed a HF-
HP diet. Also in the postprandial state, after 1 and 12 weeks of the
respective diets, TG levels were significantly elevated by HP
feeding (p= 0.0070 and p=0.0016, respectively, Figure 3 B). HF
feeding had only a significant effect on increased plasma TG after
1 week (p = 0.0130). b-hydroxybutyrate (BHB) significantly
increased in response to HP feeding after 1 week of diet
(p#0.0001, Figure 3 C). After 12 weeks the protein effect was
not significant anymore (p = 0.0559). However, compared to the
reference group, animals fed the LF-HP and HF-HP diet for 12
weeks had around 50% higher plasma BHB levels (p = 0.0090 and
p= 0.0557, respectively).
Hepatic gene expression in response to HP feeding
Hepatic gene expression was determined by microarray analysis
of pooled RNA samples. Gene set enrichment analysis revealed
several clusters of processes being enriched as a result of HP
feeding independent of the background diet and the time point
(Figure 4). A first cluster of processes enriched in the liver of HP-
fed animals compared to NP fed animals is involved in amino acid
and nitrogen metabolism (amino acid catabolism, amino acid
transport, transamination, nitrogen metabolism, translation and
serine protease inhibitor). Gene sets describing energy and
oxidative metabolism (nucleotide biosynthesis, TCA cycle and
oxidative phosphorylation, biosynthesis of mitochondria, oxidative
stress response, sterol metabolism) were likewise enriched under
HP-feeding while adipogenesis and carboxylesterase were en-
riched under NP conditions. Other gene sets enriched by NP
feeding compared to HP feeding include those related to immune
function such as adaptive and innate immune response and
activity of transcription factors as well as induction of genes related
to metal cluster binding. Details for all processes as well as heat
maps of genes responsible for the enrichment of selected clusters
Figure 4. Enrichment map for HP versus NP feeding to identify biological functions. The map displays the enriched gene-sets in HP fed vs.
NP fed mice, independent of background diet and time. Nodes represent gene-sets while edges represent overlapping genes. Gene-sets that did not
pass the enrichment significance threshold (p#0.005 and false discovery rate (FDR) #0.1) are not shown. Red node colour represents enrichment in
HP fed animals (or induction by HP diet), whereas green represents enrichment in NP fed animals (or suppression by HP diet). Clusters of functionally
related gene-sets were manually circled and assigned a label.
doi:10.1371/journal.pone.0047303.g004
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can be found under supporting information (enrichment map with
gene set names, Figure S1; heat maps of selected gene sets,
Table S1). Gene sets describing de novo lipogenesis and fatty acid
oxidation were not significantly enriched. All genes contained in
gene sets describing fatty acid oxidation are expressed in table S1.
Discussion
This study confirms that mice fed a high fat-normal protein diet
gained significantly more weight, adipose tissue mass and liver fat
compared to all other groups despite a similar energy intake
[16,17]. It further shows that in contrast to fat a high protein
content in the diet induced a lower weight gain, a lower adipose
tissue mass and a lower accumulation and storage of fat in the liver
compared to all other groups. Interestingly the present study shows
that the reducing effect of protein on adipose tissue mass and liver
fat occurred both under high and low fat conditions. This suggests
a specific effect of protein in liver independent of the fat and
carbohydrate content of the diet. These results are in line with
previous observations in which dietary protein reduced adiposity
in rats [23,30] and humans [31,32] during short term interven-
tions. Increasing protein intake was also reported to reduce liver
fat accumulation in rats [23] and mice [22] as well as in the
context of high fat diet in human [15]. This was earlier interpreted
as both a direct and indirect action of AA. However, the question
why energy in the form of amino acids is less efficiently transferred
to fat in the liver still remained unsolved [33].
The present results are in agreement with the idea that in order
to handle the overflow of incoming AA under HP feeding, AA
uptake capacity in the liver increases. Also hepatic genes involved
in AA deamination and metabolism are induced whereas the use
of AA for liver protein synthesis mainly remains unaffected. The
results of GSEA revealed that HP feeding both in context of a high
fat or a high carbohydrate diet strongly affects hepatic gene
expression in mice. This effect includes induction of gene sets
belonging to AA processing pathways such as AA transport and
catabolism, transamination processes and nitrogen metabolism. In
previous observations HP diet enhanced liver transporter activity
and AA uptake in rats [30]. Accordingly, the present study shows
that liver expression of membrane transport proteins of the solute
carrier (Slc) family was enhanced in mice adapted to the HP diet.
It was also earlier observed in rats that the increased quantity of
AA taken up by the liver was unable to further increase liver
protein synthesis compared to a normal protein diet. The excess of
AA was thus not used for protein synthesis but subjected to
deamination with the release of amino acid-derived carbon
skeleton [34,35,36]. Extending these observations, the present
study shows no modification of genes involved in liver protein
synthetic pathways, whereas there is an induction of catabolic gene
sets (Figure 4). They contain a large number of amino transferases
and transaminases (Table S1, AA_catabolism) as well as gene sets
involved in metabolism of single AA, amongst others histidine,
glycine, arginine and phenylalanine.
In contrast to earlier findings, in the present study GSEA did
not reveal any effects of the HP diet on de novo lipogenesis [37,38].
In our analysis we focused on the effect of the high protein diet
independent from the background diet. De novo lipogenesis was
repeatedly demonstrated to be reduced during high fat feeding
[39,40,41] and is possibly a result of decreased carbohydrate
intake. This effect should therefor occur in both HF groups and
the possible additional effect of increasing dietary protein plays a
less important role under these conditions.
It was also previously reported in rats that in response to HP
feeding hepatic gluconeogenesis remains induced in the fed state
[42]. Our observations in mice reveal an induction of gene sets
affecting carbohydrate metabolism and more specifically genes
linked to gluconeogenesis (Figure 4). However, it also has been
reported that the amount of AA-derived carbon skeletons used for
gluconeogenesis is very limited and this pathway cannot cope with
the excess of incoming AA under HP feeding [43]. The present
study indicates that in order to handle the excess of AA taken up
by the liver that are not used for protein synthesis or
gluconeogenesis under HP feeding, hepatic capacity for AA
oxidative deamination processes increases (Figure 4). Indeed,
biosynthesis of mitochondria and sets of genes encoding enzymes
of the TCA cycle and oxidative phosphorylation were induced in
the liver by a HP diet in mice. Via transamination reactions AA
are metabolised into a-keto acids, then converted into acetyl-CoA,
succinyl-CoA, fumarate, a-keto glutarate and oxaloacetate which
subsequently enter the mitochondrial TCA cycle. The direct
supply of dietary AA into the TCA cycle when fed a HP diet was
described earlier [43]. NADH is generated in the TCA cycle,
which is a precursor required for oxidative phosphorylation and
generation of ATP (Table S1, TCA_cycle). Genes related to
oxidative phosphorylation are encoding different sub-complexes of
enzymes like cytochrome c oxidase, NADH dehydrogenase and
ATP synthase (Table S1, oxidative_phosphorylation). An energy
restricted HP diet was previously described to induce a stronger
increase in mitochondrial oxidation compared to a normal energy
restricted diet [44]. Moreover, in rats adapting to a HP diet a
transient drop in carbohydrate oxidation and increase in protein
oxidation was observed [42,43]. In humans, both without and
after adaptation to a HP diet, basal protein oxidation and post-
prandial energy expenditure in response to a HP meal were higher
compared to the control condition [45]. Fatty acid oxidation was
Figure 5. Schematic fate of dietary amino acid utilisation in the
liver. Dietary amino acids are firstly used for protein synthesis;
however, this can only happen to a limited extent. Subsequently,
carbon skeletons can be utilised for gluconeogenesis in a very limited
amount. An overload of the liver with dietary amino acids promotes
catabolism to acetyl-CoA. Synthesised acetyl-CoA is either channelled
into the TCA cycle or used for BHB production. With increasing
ingestion of protein, amino acid oxidation and production of BHB from
acetyl-CoA becomes more important in relation to gluconeogenesis
and protein synthesis.
doi:10.1371/journal.pone.0047303.g005
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not detected to be altered in the present study. This is in line with
previous data from rats which demonstrated that postprandial
lipid oxidation increases on the first day of a HP diet, but returns
to baseline during adaptation [42]. In human post prandial lipid
oxidation was even suggested to decrease after adaptation to a HP
diet [45]. Tremendous increases in acetyl-CoA, inhibiting b-
oxidation may explain these findings.
Interestingly, the HP diet increased plasma b-hydroxybutyrate
(BHB) levels, suggesting the induction of a fasting-like situation
and a channelling of the excess of acetyl-CoA to BHB synthesis. It
is likely that during HP feeding the increased catabolism of AA
acids induces an overflow of acetyl-CoA exceeding the cellular
energy requirements. In the liver it is not converted into fat but
into BHB that is excreted and may act as energy source for
extrahepatic organs. The HP diet increased postprandial plasma
TG which suggests a larger excretion of hepatic lipids via VLDL
which at the same time decreases lipid storage. Indeed VLDL
production rate decreases with a HF-NP diet but this effect is
restored under HF-HP conditions. In humans increased postpran-
dial TG levels in response to a HP adaptation were likewise
observed [45]. Although an increased formation of apolipoproteins
is not detected on a transcriptional level, this does not exclude the
possibility that due to the high influx amino acids lipoprotein
synthesis will increase. This will stimulate hepatic formation and
excretion of VLDL particles. Other processes enriched under HP
conditions are related to oxidative stress response. The high rate of
mitochondrial oxidation confronts the liver with large amount of
reactive electrophiles and changes the redox state of hepatocytes
leading to an activation of Nrf2 [46]. Part of the Nrf2 target genes
belong to the glutathione (GSH)-dependent detoxification system
[47], encompassing amongst others glutathione synthase and
glutathione peroxidases for neutralising oxidative stress (Table S1,
oxidative_stress_response). Moreover, several genes of the gluta-
thione S-transferase (GST) family are overexpressed under HP
feeding. GST catalyses the conjugation of reduced GSH to
electrophiles, e.g. lipid peroxides, thereby protecting against
peroxidation [48]. GSH is regenerated by glutathione reductase
(GSR). The hepatic synthesis of GSH uses AA (cysteine, glutamate
and glycine) provided by the HP diet [48]. These processes require
energy in form of ATP, which is not available for other metabolic
functions or storage as lipid.
Taken together, the present data suggest that at a similar energy
intake, mice ingesting HP as compared to NP diets possess a lower
body weight, adiposity and hepatic fat due to a combination of
modulated processes (Figure 5). Firstly, the hepatic capacity to
store AA as protein is limited and the excess AA is deaminated
possibly to prevent a rise in cellular and blood AA concentration.
Secondly, as the transfer of AA-derived carbon to glucose also is
limited and de novo lipogenesis seems absent, these carbon skeletons
are metabolized and transferred to acetyl-CoA. Thirdly, as result
of an overload of acetyl-CoA and limited capacities to further
metabolise it, energy is excreted from the liver in form of BHB and
can act as a substrate to extrahepatic organs. In addition, more
energy has to be used for detoxification of electrophiles produced
during protein catabolism. Thus, handling of large amounts of
amino acids leads to an increased energy utilisation in the liver. At
the same time hepatic lipid storage is reduced. Additional effects
contributing to the leaner phenotype of HP fed mice might be a
slight, non-significant reduction in food intake, modifications in
intestinal microbiota resulting in reduced nutrient availability as
well as increased thermogenesis and therefore easier maintenance
of body temperature at 20uC. This, however, has to be subject to
further investigation. At last, HP in comparison with NP feeding
promoted down regulation of both adaptive and innate immunity.
Fatty liver is often associated with inflammation [16]. The
diminished hepatic lipid content in HP-fed animals prevented an
increase in inflammation markers and a response of the immune
system, even explicit inflammation was not yet detected in NP fed
mice.
In conclusion, the liver plays a buffering role in preventing the
extrahepatic tissues from an overload of AA. Moreover, a shift in
energy from the liver to peripheral tissues and its use for example
in muscle are suggested and should be further investigated also on
a longer term.
Supporting Information
Figure S1 Enrichment map for HP versus NP feeding to
identify biological functions. The map displays the enriched
gene-sets and their labels in HP fed vs. NP fed mice, independent
of background diet and time. Nodes represent gene-sets while
edges represent overlapping genes. Gene-sets that did not pass the
enrichment significance threshold (p#0.005 and false discovery
rate (FDR) #0.1) are not shown. Red node colour represents
enrichment in HP fed animals (or induction by HP diet), whereas
green represents enrichment in NP fed animals (or suppression by
HP diet). Clusters of functionally related gene-sets were manually
circled and assigned a label.
(PDF)
Table S1 Heat maps of genes contributing to the
enrichment of the gene sets within selected clusters of
processes. For each of those genes, fold changes (FC) of signal
intensity of the treatment group in comparison with the reference
group at week 0 were calculated and expressed in a heat map. Red
colour represents up regulation and green colour represents down
regulation of a gene in comparison with the reference group.
Additionally, genes contained in gene sets describing fatty acid
oxidation are expressed.
(XLSX)
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